Aadi Bioscience, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.1Mgeneral payments (2019-2025)
$94Kresearch payments (2019-2025)
759clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Caley Castelein | Miami Beach, FL | General Practice | $277,597.39 |
| George Demetri | Boston, MA | Medical Oncology | $122,098.73 |
| Kamalesh Sankhala | Beverly Hills, CA | Medical Oncology | $58,426.13 |
| Susan Jerian | Westlake Village, CA | Internal Medicine | $44,450.00 |
| Ralph Boccia | Bethesda, MD | Hematology & Oncology | $33,500.00 |
| Thomas Herzog | Cincinnati, OH | Gynecologic Oncology | $32,490.37 |
| Arun Singh | Santa Monica, CA | Hematology & Oncology | $26,366.69 |
| Martee Hensley | New York, NY | Medical Oncology | $17,759.08 |
| Brian Slomovitz | Fort Lauderdale, FL | Gynecologic Oncology | $17,524.18 |
| Kathleen Moore | Oklahoma City, OK | Obstetrics & Gynecology | $14,689.84 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.